Forum Article · Volume 14, Issue 3 · pp. 266–267
Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective
Pugazhenthan Thangaraju1, Sree Sudha TY2, Sajitha Venkatesan3
- 1Department of Pharmacology, AIIMS, Raipur, Chhattisgarh, INDIA.
- 2Department of Pharmacology, AIIMS, Deogarh, Jharkhand, INDIA.
- 3Department of Microbiology, AIIMS, Raipur, Chhattisgarh, INDIA.
Abstract
Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region.
The full text of this article is available as a PDF. Open the PDF.